MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
AsthmaCOPDHealthy
Interventions
DRUG

HXe MRI lung ventilation

MagniXene (HXe) is an Investigational New Drug made of xenon noble gas. Through a physical process using alkali vapors and powerful lasers, xenon atoms have their nuclear spin preferentially aligned (hyperpolarized), thus offering a highly enhanced signal inside an MRI scanner. High-resolution images of the lung spaces are acquired within a short breath-hold after inhalation of HXe.

Trial Locations (1)

22903

University of Virginia, Charlottesville

All Listed Sponsors
collaborator

University of Virginia

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Xemed LLC

INDUSTRY

NCT01833390 - MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects | Biotech Hunter | Biotech Hunter